Richard Staub and President - Free people check

(1 - 19 from 21

)

Quintiles, PPD veteran named to biz dev post at CRO Novella

medcitynews.com

Novella Clinical has named Nick Dyer to be the CRO's new executive vice president overseeing global business development. Read why Novella hired Dyer.

Data.com: Richard Staub

Job: President; City: Virginia Beach; Company: Datacable Technologies Inc

Data.com: Richard Staub

Job: President and Chief Executive Officer; City: Durham; Company: PharmaLinkFHI Inc

Data.com: Richard Staub

Job: President/Chief Executive Officer; City: Morrisville; Company: Novella Clinical

Novella Clinical's President & CEO Richard Staub Wins Ernst & Young...

www.tmcnet.com

Novella Clinical's President & CEO Richard Staub Wins Ernst & Young Entrepreneur of the Year® Carolinas Award

QuintilesIMS Announces Executive Leadership Changes | Business Wire

www.businesswire.com

· Quintiles IMS Holdings, Inc. (NYSE:Q) announced today the appointment of Richard Staub III, currently president of Novella Clinical, a Quintiles compa

Richard Staub - Email, Phone - President and Chief Executive Officer,...

www.adapt.io

Richard Staub's email address , contact phone/mobile number +1******66. Working in Novella Clinical as President and Chief Executive...

W. Richard Staub III. Richard Staub is president of the Research & Development Solutions global business unit at IQVIA, where he leads the world’s largest contract research organization (CRO). Supported by high-powered information and technology assets, the clinical experts in R&D Solutions leverage comprehensive, evidence-driven trial design ...

W. Richard Staub - Biography

www.marketscreener.com

W. Richard Staub is on the board of TLC Operations, Inc. and President-Research & Development Solutions at IQVIA Holdings, Inc. In the past Mr. Staub occupied...

An Interview with Novella Clinical CEO Richard Staub

www.appliedclinicaltrialsonline.com

Last August, Quintiles announced its intention to purchase Novella Clinical, specifically for its focus on small and mid-sized oncology biopharma clients, as well as medical device and diagnostics companies. We checked in with Novella President Richard Staub to discuss post-acquisition life, outsourcing, ...

W. Richard Staub III - SourceWatch

www.sourcewatch.org

W. Richard Staub, III President and Chief Operating Officer of PharmaLink. "In July 2004, Mr. Staub became PharmaLink's President and Chief Operating Officer.

QuintilesIMS Announces Executive Leadership Changes

finance.yahoo.com

Quintiles IMS Holdings, Inc. announced today the appointment of Richard Staub III, currently president of Novella Clinical, a Quintiles company, ...

Compensation Information for W. Richard Staub III, President,...

www1.salary.com

Salary, bonuses, stock options, stock awards and other compensation for W. Richard Staub III, President, Research & Development Solutions at IQVIA HOLDINGS...

Novella Clinical’s President & CEO Richard Staub Wins Ernst & Young...

www.biospace.com

RESEARCH TRIANGLE PARK, N.C.----Novella Clinical, Inc., a full service contract research organization, is proud to announce President & CEO Richard

PHLCVB Press Room | Hotel Industry Veteran Richard Staub Joins...

phl.travmedia.com

HOTEL INDUSTRY VETERAN RICHARD STAUB JOINS PHILADELPHIA CONVENTION & VISITORS BUREAU AS SENIOR VICE PRESIDENT ...

New Hire for PHLCVB | Northeast

ne.meetingsmags.com

Philadelphia Convention and Visitors Bureau has selected Richard Staub as the senior vice president, convention sales. In his role, Staub will be in charge of...

Novella CEO Staub to head QuintilesIMS' R&D solutions unit |...

www.fiercebiotech.com

The executive shake-up following the formation of QuintilesIMS last month continues, with the appointment of CRO veteran Richard Staub as president of the...

IQVIA | CEO Roundtable on Cancer

www.ceoroundtableoncancer.org

Richard Staub is president of the Research & Development Solutions global business unit, leading the world's largest contract research organization (CRO). Supported by high-powered information and technology assets, the clinical experts in R&D Solutions leverage comprehensive, evidence-driven trial design, accelerate ...